Circulating Nucleic Acids in Plasma or Serum (CNAPS) as Prognostic and Predictive Markers in Patients with Solid Neoplasias
Open Access
- 1 January 2005
- journal article
- review article
- Published by Wiley in Disease Markers
- Vol. 21 (3) , 105-120
Abstract
It is now widely accepted that there is a need for the development of molecular markers of cancer that can be used for clinical prognostication and monitoring. Approximately a decade ago tumor‐derived circulating nucleic acids in the plasma or serum (CNAPS) of cancer patients were introduced as a noninvasive tool for cancer detection. This review focuses on the various types of CNAPS of patients with solid neoplasias (genetic alterations in circulating DNA, microsatellites, methylated DNA, viral DNA, nucleosomes, mitochondrial DNA and cell‐free mRNA) and their putative potential as prognostic or predictive parameter or even as a tool for therapy monitoring during follow‐up. Additionally, this review aims to point out the difference between a prognostic and a predictive factor in patient bloodstream. However, with rapid technical improvement and well‐designed studies we conclude that the next years will see CNAPS analysis integrated in the prognostication and monitoring of cancer patients, thus producing more specific treatment regimens for patients with various stages of neoplastic disease and ultimately longer survival and better quality of life.Keywords
Funding Information
- Jubiläumsfonds der Österreichischen Nationalbank (10929)
This publication has 67 references indexed in Scilit:
- CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patientsInternational Journal of Cancer, 2003
- Pretherapy quantitative measurement of circulating Epstein–Barr virus DNA is predictive of posttherapy distant failure in patients with early‐stage nasopharyngeal carcinoma of undifferentiated typeCancer, 2003
- Circulating nucleosomes and response to chemotherapy: An in vitro, in vivo and clinical study on cervical cancer patientsInternational Journal of Cancer, 2003
- Detection of free‐circulating tumor‐associated DNA in plasma of colorectal cancer patients and its association with prognosisInternational Journal of Cancer, 2002
- Tumor p16M is a possible marker of advanced stage in non–small cell lung cancerJournal of Surgical Oncology, 2002
- Detection of mitochondrial DNA alterations in primary tumors and corresponding serum of colorectal cancer patientsInternational Journal of Cancer, 2001
- Low Incidence of HPV DNA in Sera of Pretreatment Cervical Cancer PatientsGynecologic Oncology, 2001
- Nucleosomes in serum of patients with benign and malignant diseasesInternational Journal of Cancer, 2001
- Plasma nucleosome levels in node-negative breast cancer patientsBreast Cancer, 1999
- Mutant K-ras in apparently normal mucosa of colorectal cancer patients. Its potential as a biomarker of colorectal tumorigenesisCancer, 1995